Influence of Pretransplant Panel-Reactive Antibody on Outcomes in 8,160 Heart Transplant Recipients in Recent Era

Lois U. Nwakanma, Jason A. Williams, Eric S. Weiss, Stuart D. Russell, William A. Baumgartner, John V. Conte

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

Background: Panel-reactive antibody (PRA) screening to detect HLA antibodies is an important part of evaluation for potential heart transplant recipients. We sought to determine how different levels of PRA affect outcomes in heart transplantation. Methods: A retrospective cohort study of using data reported to the United Network for Organ Sharing /Organ Procurement and Transplantation Network (UNOS/OPTN) registry from January 1, 2000, to December 31, 2004, was performed. The association between PRA at transplant and primary end points, allograft and patient survival, as well as a secondary end point, rejection within 1 year, was analyzed. Results: Pretransplant PRA was reported for 8,160 (79.4%) of the 10,279 first heart transplant recipients during the study period. Panel-reactive antibody was 0% in 6,481 (79.4%) patients (group 1), 1% to 10% in 930 (11.4%) patients (group 2), 11% to 25% in 309 (3.8%) patients (group 3), and greater than 25% in 440 (5.4%) patients (group 4). Actuarial survival was significantly different among the four groups by Kaplan-Meier method (p < 0.001). Furthermore, using PRA cutoffs of 0%, 10%, or 25%, the group with lower PRA had significantly better patient and allograft survival. Cox proportional hazard modeling revealed increasing PRA as a significant predictor of mortality (p < 0.001). However, when each group (2, 3, and 4) was compared with group 1 (PRA 0%), only group 4 (PRA > 25%) had worse survival on multivariate analysis. Patients with PRA greater than 25% confirmed by the flow cytometric technique had the worst overall survival. Rejection rate within 1 year after transplantation also significantly increased with increasing PRA. Propensity-matched patients demonstrated similar results. Conclusions: This large series of patients from the United Network for Organ Sharing database has demonstrated that elevated PRA remains a significant risk factor in a recent cohort of heart transplant recipients. Patients with PRA greater than 25% are at a particularly high risk.

Original languageEnglish (US)
Pages (from-to)1556-1563
Number of pages8
JournalAnnals of Thoracic Surgery
Volume84
Issue number5
DOIs
StatePublished - Nov 1 2007

Fingerprint

Antibodies
Survival
Transplant Recipients
Tissue and Organ Procurement
Organ Transplantation
Heart Transplantation
Allografts
Registries
Cohort Studies
Multivariate Analysis
Retrospective Studies
Transplantation
Databases
Transplants

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Nwakanma, Lois U. ; Williams, Jason A. ; Weiss, Eric S. ; Russell, Stuart D. ; Baumgartner, William A. ; Conte, John V. / Influence of Pretransplant Panel-Reactive Antibody on Outcomes in 8,160 Heart Transplant Recipients in Recent Era. In: Annals of Thoracic Surgery. 2007 ; Vol. 84, No. 5. pp. 1556-1563.
@article{da3347cd7d904701b0276e10a3b08780,
title = "Influence of Pretransplant Panel-Reactive Antibody on Outcomes in 8,160 Heart Transplant Recipients in Recent Era",
abstract = "Background: Panel-reactive antibody (PRA) screening to detect HLA antibodies is an important part of evaluation for potential heart transplant recipients. We sought to determine how different levels of PRA affect outcomes in heart transplantation. Methods: A retrospective cohort study of using data reported to the United Network for Organ Sharing /Organ Procurement and Transplantation Network (UNOS/OPTN) registry from January 1, 2000, to December 31, 2004, was performed. The association between PRA at transplant and primary end points, allograft and patient survival, as well as a secondary end point, rejection within 1 year, was analyzed. Results: Pretransplant PRA was reported for 8,160 (79.4{\%}) of the 10,279 first heart transplant recipients during the study period. Panel-reactive antibody was 0{\%} in 6,481 (79.4{\%}) patients (group 1), 1{\%} to 10{\%} in 930 (11.4{\%}) patients (group 2), 11{\%} to 25{\%} in 309 (3.8{\%}) patients (group 3), and greater than 25{\%} in 440 (5.4{\%}) patients (group 4). Actuarial survival was significantly different among the four groups by Kaplan-Meier method (p < 0.001). Furthermore, using PRA cutoffs of 0{\%}, 10{\%}, or 25{\%}, the group with lower PRA had significantly better patient and allograft survival. Cox proportional hazard modeling revealed increasing PRA as a significant predictor of mortality (p < 0.001). However, when each group (2, 3, and 4) was compared with group 1 (PRA 0{\%}), only group 4 (PRA > 25{\%}) had worse survival on multivariate analysis. Patients with PRA greater than 25{\%} confirmed by the flow cytometric technique had the worst overall survival. Rejection rate within 1 year after transplantation also significantly increased with increasing PRA. Propensity-matched patients demonstrated similar results. Conclusions: This large series of patients from the United Network for Organ Sharing database has demonstrated that elevated PRA remains a significant risk factor in a recent cohort of heart transplant recipients. Patients with PRA greater than 25{\%} are at a particularly high risk.",
author = "Nwakanma, {Lois U.} and Williams, {Jason A.} and Weiss, {Eric S.} and Russell, {Stuart D.} and Baumgartner, {William A.} and Conte, {John V.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.athoracsur.2007.05.095",
language = "English (US)",
volume = "84",
pages = "1556--1563",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

Influence of Pretransplant Panel-Reactive Antibody on Outcomes in 8,160 Heart Transplant Recipients in Recent Era. / Nwakanma, Lois U.; Williams, Jason A.; Weiss, Eric S.; Russell, Stuart D.; Baumgartner, William A.; Conte, John V.

In: Annals of Thoracic Surgery, Vol. 84, No. 5, 01.11.2007, p. 1556-1563.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Influence of Pretransplant Panel-Reactive Antibody on Outcomes in 8,160 Heart Transplant Recipients in Recent Era

AU - Nwakanma, Lois U.

AU - Williams, Jason A.

AU - Weiss, Eric S.

AU - Russell, Stuart D.

AU - Baumgartner, William A.

AU - Conte, John V.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Background: Panel-reactive antibody (PRA) screening to detect HLA antibodies is an important part of evaluation for potential heart transplant recipients. We sought to determine how different levels of PRA affect outcomes in heart transplantation. Methods: A retrospective cohort study of using data reported to the United Network for Organ Sharing /Organ Procurement and Transplantation Network (UNOS/OPTN) registry from January 1, 2000, to December 31, 2004, was performed. The association between PRA at transplant and primary end points, allograft and patient survival, as well as a secondary end point, rejection within 1 year, was analyzed. Results: Pretransplant PRA was reported for 8,160 (79.4%) of the 10,279 first heart transplant recipients during the study period. Panel-reactive antibody was 0% in 6,481 (79.4%) patients (group 1), 1% to 10% in 930 (11.4%) patients (group 2), 11% to 25% in 309 (3.8%) patients (group 3), and greater than 25% in 440 (5.4%) patients (group 4). Actuarial survival was significantly different among the four groups by Kaplan-Meier method (p < 0.001). Furthermore, using PRA cutoffs of 0%, 10%, or 25%, the group with lower PRA had significantly better patient and allograft survival. Cox proportional hazard modeling revealed increasing PRA as a significant predictor of mortality (p < 0.001). However, when each group (2, 3, and 4) was compared with group 1 (PRA 0%), only group 4 (PRA > 25%) had worse survival on multivariate analysis. Patients with PRA greater than 25% confirmed by the flow cytometric technique had the worst overall survival. Rejection rate within 1 year after transplantation also significantly increased with increasing PRA. Propensity-matched patients demonstrated similar results. Conclusions: This large series of patients from the United Network for Organ Sharing database has demonstrated that elevated PRA remains a significant risk factor in a recent cohort of heart transplant recipients. Patients with PRA greater than 25% are at a particularly high risk.

AB - Background: Panel-reactive antibody (PRA) screening to detect HLA antibodies is an important part of evaluation for potential heart transplant recipients. We sought to determine how different levels of PRA affect outcomes in heart transplantation. Methods: A retrospective cohort study of using data reported to the United Network for Organ Sharing /Organ Procurement and Transplantation Network (UNOS/OPTN) registry from January 1, 2000, to December 31, 2004, was performed. The association between PRA at transplant and primary end points, allograft and patient survival, as well as a secondary end point, rejection within 1 year, was analyzed. Results: Pretransplant PRA was reported for 8,160 (79.4%) of the 10,279 first heart transplant recipients during the study period. Panel-reactive antibody was 0% in 6,481 (79.4%) patients (group 1), 1% to 10% in 930 (11.4%) patients (group 2), 11% to 25% in 309 (3.8%) patients (group 3), and greater than 25% in 440 (5.4%) patients (group 4). Actuarial survival was significantly different among the four groups by Kaplan-Meier method (p < 0.001). Furthermore, using PRA cutoffs of 0%, 10%, or 25%, the group with lower PRA had significantly better patient and allograft survival. Cox proportional hazard modeling revealed increasing PRA as a significant predictor of mortality (p < 0.001). However, when each group (2, 3, and 4) was compared with group 1 (PRA 0%), only group 4 (PRA > 25%) had worse survival on multivariate analysis. Patients with PRA greater than 25% confirmed by the flow cytometric technique had the worst overall survival. Rejection rate within 1 year after transplantation also significantly increased with increasing PRA. Propensity-matched patients demonstrated similar results. Conclusions: This large series of patients from the United Network for Organ Sharing database has demonstrated that elevated PRA remains a significant risk factor in a recent cohort of heart transplant recipients. Patients with PRA greater than 25% are at a particularly high risk.

UR - http://www.scopus.com/inward/record.url?scp=35348876671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348876671&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2007.05.095

DO - 10.1016/j.athoracsur.2007.05.095

M3 - Article

C2 - 17954062

AN - SCOPUS:35348876671

VL - 84

SP - 1556

EP - 1563

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -